Portola Pharmaceutical Shares Trading Up On High Volume

October 1, 2014 12:40 PM

2 0

Portola Pharmaceutical Shares Trading Up On High Volume

Shares of Portola Pharmaceutical, Inc. (NASDAQ: PTLA) are trading up over 15% to $29.14 per share on high-volume after the company announced that its first Phase 3 study of andexanet alfa, a potential universal Factor Xa inhibitor antidote and U.S. Food and Drug Administration-designated breakthrough therapy, met its primary and secondary endpoints with high statistical significance.

Normal trading volume is 269,000 shares per day and three hours into the trading day Portola Pharmaceutical has traded nearly 600,000 shares.

Also read: Trump to pick billionaire Wilbur Ross as Commerce secretary

Read more

To category page

Loading...